A covered individual's defined cost sharing for a prescription drug must be:
- (1) calculated at the point of sale; and
- (2) based on a price that is reduced by an amount equal to at least eighty-five percent (85%) of all rebates in connection with the dispensing or administration of the prescription drug.
As added by P.L.166-2023, SEC.2.